Investing in Precision Medicine
Tech-powered personalized treatments
The power of advanced medical technology is coming to a doctor’s office near you. Instead of prescribing drugs or treatments which are one size fits all, artificial intelligence and other technologies allow doctors to use those that are tailor made for an individual patient. Join us on March 28th to take a look under the digital microscope at cost-effective DNA testing, protein identification, advanced disease screening and more with the CEOs and top advisors of three cutting-edge OurCrowd portfolio companies Genopore, OncoHost and Sequentify.
Speakers:
- Prof. Aaron Ciechanover – Nobel Laureate and Scientific Advisor to OncoHost
- David (Dudi) Baum– Co-Founder & CEO, Genopore
- Ophir Herbst – Co-Founder & CEO, Sequentify
- Dr. Ofer Sharon– CEO, OncoHost
- Dr. Liran Shlush – Senior Scientist, Weizmann Institute, Sequentify Medical Advisor
- Host: Jon Medved, Founder & CEO, OurCrowd
Monday, March 28, 2022
Virtual
Tech-powered personalized treatments
The power of advanced medical technology is coming to a doctor’s office near you. Instead of prescribing drugs or treatments which are one size fits all, artificial intelligence and other technologies allow doctors to use those that are tailor made for an individual patient. Join us on March 28th to take a look under the digital microscope at cost-effective DNA testing, protein identification, advanced disease screening and more with the CEOs and top advisors of three cutting-edge OurCrowd portfolio companies Genopore, OncoHost and Sequentify.
Speakers:
- Prof. Aaron Ciechanover – Nobel Laureate and Scientific Advisor to OncoHost
- David (Dudi) Baum– Co-Founder & CEO, Genopore
- Ophir Herbst – Co-Founder & CEO, Sequentify
- Dr. Ofer Sharon– CEO, OncoHost
- Dr. Liran Shlush – Senior Scientist, Weizmann Institute, Sequentify Medical Advisor
- Host: Jon Medved, Founder & CEO, OurCrowd